Resistance Exercise Blood Flow Restriction (BFRCL)

December 4, 2024 updated by: Cameron Mitchell, University of British Columbia

Skeletal Muscle Endurance Responses to Various Relative Loads of Dynamic Resistance Exercise with and Without Peripheral Blood Flow Occlusion

The number of repetitions able to be performed during resistance exercise is impacted by the load an individual is working against. Heavier loads lead to less repetitions being performed and lighter loads lead to more repetitions being performed. As the load gets progressively lighter, it is hypothesized that oxygen availability becomes an important factor for performance of maximum repetitions. Peripheral blood flow occlusion using exercise specific blood flow occlusion cuffs can allow for oxygen availability to be controlled by altering the amount of blood able to get to working muscles. To date, no study has examined the effect of varying exercise loads, from heavy to light, on maximum repetitions able to be performed with and without blood flow occlusion.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The study aims to assess the difference in maximum repetitions performed at varying percentages of participants maximum strength and the impact peripheral blood flow occlusion has on performance

The study will take three weeks to complete with a total of six visits. The entire time commitment will be seven hours. During week 1 participants will visit the lab twice to perform baseline assessments of strength, endurance, muscle size and will also receive a resting thighs muscle biopsy. During weeks 2 and 3 participants will visit the lab twice per week to complete three out of twelve randomized exercise interventions per visit. The interventions are maximum repetitions at 80/40/30/25/20/15% of knee-extension one-repetition maximum as well as 90/70/60/55/50/45% of barbell curl one-repetition maximum; all of the listed conditions will be tested in a free-flow and blood flow occluded state (i.e., 12 total exercise interventions for the knee extension and 12 total exercise interventions for the barbell curl).

Study Type

Interventional

Enrollment (Actual)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V6T 1Z3
        • Chan Gunn Pavilion

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Able to understand and communicate in English
  2. 19-30 years of age
  3. All "No" answers on the Canadian Society for Exercise Physiology Get Active questionnaire or doctors' approval to participate
  4. Untrained participants: no structured resistance and/or endurance training over the past 12-months (i.e., >2 hours per week of structured/periodized training)
  5. Resistance trained participants: structured resistance training over the past 12-months (i.e., >2 hours per week of structured/periodized resistance training)
  6. Endurance trained participants: structured resistance training over the past 12-months (i.e., >2 hours per week of structured/periodized endurance training)

Exclusion Criteria:

  1. BMI lower than 18 or greater than 30
  2. Current use of cigarettes or other nicotine devices
  3. Any major uncontrolled cardiovascular, muscular, metabolic, and/or neurological disorders
  4. Any medical condition impacting the ability to participate in maximal exercise
  5. Type one or type two diabetes
  6. Diagnosis of cancer or undergoing cancer treatment in the past 12 months
  7. Taking blood-thinning medication or the presence of a bleeding disorder
  8. Drug therapy with any drugs that alter skeletal muscle metabolism (i.e., Metformin, Benzodiazepines)
  9. Lowest calculated exercise testing load is less than the lightest weight able to be provided by the lab gymnasium equipment (i.e., 36 pounds for the knee extension, and/or 33 pounds for the barbell curl)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 80% knee extension/80% barbell curl 1RM
The load will be set to 80% of 1RM for the knee extension and 80% 1RM for the barbell curl
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 40% knee extension/70% barbell curl 1RM
The load will be set to 40% of 1RM for the knee extension and 70% 1RM for the barbell curl
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 30% knee extension/60% barbell curl 1RM
The load will be set to 30% of 1RM for the knee extension and 60% 1RM for the barbell curl
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 25% knee extension/55% barbell curl 1RM
The load will be set to 25% of 1RM for the knee extension and 55% 1RM for the barbell curl
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 20% knee extension/50% barbell curl 1RM
The load will be set to 25% of 1RM for the knee extension and 50% 1RM for the barbell curl
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 15% knee extension/45% barbell curl 1RM
The load will be set to 15% of 1RM for the knee extension and 45% 1RM for the barbell curl
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 80% knee extension/80% barbell curl 1RM both with blood flow occlusion
The load will be set to 80% of 1RM for the knee extension and 80% 1RM for the barbell curl with both being under peripheral blood flow occlusion
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 40% knee extension/60% barbell curl 1RM both with blood flow occlusion
The load will be set to 40% of 1RM for the knee extension and 60% 1RM for the barbell curl with both being under peripheral blood flow occlusion
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 30% knee extension/60% barbell curl 1RM both with blood flow occlusion
The load will be set to 30% of 1RM for the knee extension and 60% 1RM for the barbell curl with both being under peripheral blood flow occlusion
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 25% knee extension/55% barbell curl 1RM both with blood flow occlusion
The load will be set to 25% of 1RM for the knee extension and 55% 1RM for the barbell curl with both being under peripheral blood flow occlusion
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 20% knee extension/50% barbell curl 1RM both with blood flow occlusion
The load will be set to 20% of 1RM for the knee extension and 50% 1RM for the barbell curl with both being under peripheral blood flow occlusion
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Experimental: 15% knee extension/45% barbell curl 1RM both with blood flow occlusion
The load will be set to 15% of 1RM for the knee extension and 45% 1RM for the barbell curl with both being under peripheral blood flow occlusion
All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum knee extension repetitions
Time Frame: From weeks two to three in the study
total repetitions completed for each load condition
From weeks two to three in the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum barbell curl repetitions
Time Frame: From weeks two to three in the study
total repetitions completed for each load condition
From weeks two to three in the study
Change in vastus lateralis oxygen saturation
Time Frame: From weeks two to three in the study
The change in vastus lateralis oxygen saturation across each load condition
From weeks two to three in the study
Correlation of muscle fiber size/type/distribution to maximum knee extension repetitions at 20% 1RM
Time Frame: From weeks two to three in the study
From weeks two to three in the study
Correlation of mitochondrial content to maximum knee extension repetitions at 20% 1RM
Time Frame: From weeks two to three in the study
From weeks two to three in the study
Correlation of capillary density to maximum knee extension repetitions at 20% 1RM
Time Frame: From weeks two to three in the study
From weeks two to three in the study
Comparison of muscle fiber size/type/distribution, mitochondrial function, mitochondrial density, capillary density, absolute muscle size ,and VO2 max between participants of different training statuses
Time Frame: Week 3
Week 3
Correlation of absolute muscle size to maximum knee extension repetitions at 20% 1RM/barbell curl repetitions at 45% 1RM
Time Frame: Weeks 1, 2, and 3
Weeks 1, 2, and 3
Correlation of absolute muscle size to maximum knee extension repetitions at 20% 1RM/barbell curl repetitions at 45% 1RM
Time Frame: Week 1
Week 1
Correlation of absolute muscle size to maximum knee extension repetitions at 20% 1RM/barbell curl repetitions at 45% 1RM
Time Frame: Week 2
Week 2
Comparison of absolute muscle size between sexes
Time Frame: Week 3
Week 3
Comparison of capillary density between sexes
Time Frame: Week 3
Week 3
Comparison of mitochondrial density between sexes
Time Frame: Week 3
Week 3
Comparison of muscle fiber distribution between sexes
Time Frame: Week 3
Week 3
Comparison of muscle fiber size between sexes
Time Frame: Week 3
Week 3
Comparison of muscle fiber type between sexes
Time Frame: Week 3
Week 3
Comparison of mitochondrial function between sexes
Time Frame: Week 3
Week 3
Comparison of VO2 max between sexes
Time Frame: Week 3
Week 3
Correlation of VO2 max to maximum knee extension repetitions at 20% 1RM
Time Frame: Week 1
Week 1
Correlation of VO2 max to maximum knee extension repetitions at 20% 1RM
Time Frame: Week 2
Week 2
Correlation of VO2 max to maximum knee extension repetitions at 20% 1RM
Time Frame: Week 3
Week 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 28, 2023

Primary Completion (Actual)

November 21, 2023

Study Completion (Actual)

November 21, 2023

Study Registration Dates

First Submitted

June 9, 2023

First Submitted That Met QC Criteria

December 4, 2024

First Posted (Estimated)

December 9, 2024

Study Record Updates

Last Update Posted (Estimated)

December 9, 2024

Last Update Submitted That Met QC Criteria

December 4, 2024

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • BFRCL

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

A plan has not yet been made to make individual participant data available to other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe